The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Cannacord reducing? Or lots of level 2 trying to sell? They have made several large purchases here. Have to see if these have paid off.
This news came out today.
https://www.holmesreport.com/latest/article/huntsworth-brings-citigate-grayling-and-red-brands-closer
Citigate is basically moving closer to other brands. Apparently down to leases running out. If they had this much free office space why was this not done sooner? Worth reading above. Maybe markets have read this in the wrong way?
There's been quite a bit of selling in the past week. Folk not wanting to risk holding for trading statement, which must be imminent?
Panmure cuts Huntsworth target price to 45p from 54p?
So are they saying Huntsworth is worth half the current share price? Bizarre. It has been drifting a bit lately.
4.8%. You gotta laugh. Only on AIM :)
to Buy
Yes time to move on for now. Eventually they will have to deal with that debt. Maybe selling on less profitable or struggling units. That being said with their profits they should be able to reduce debts long term.
Agree since they were at 37p they have progressed things here well and given good return for investors. Is this share the best ROI for new investors? Not so sure. If they continue to keeping growing revenue then things could get interesting. Cash is running out without share issues.
I am pleased to see the progress Huntsworth has made over the years......and feel that it was unfortunate that I sold out before the jam appeared on top of the cream! However, I made a nice, if long awaited, profit, so I cannot complain.
My view now is that they have seen the peak for this year. I am also concerned about their increased emphasis on North America. Yes, so far it has proved to be very successful and the devaluation of the pound has also boosted profits in foreign earnings...….but what happens if the dollar starts to sink and the economy there goes pear shaped? I think I will stay out of this share for a while longer and see what happens.
Proactive investor suggests :-
' Shares in Huntworth PLC (LON:HNT) sank 9.4% to 120p in late-afternoon trading after the medical communications group reported a net cash outflow despite profit and revenue increases in its interims.
The firm reported a pre-tax profit for the half-year of £10.3mln, up from £9.2mln in the same period last year while revenues climbed to £102.2mln from £94.2mln previously.
However, despite the increases the company recorded a net cash outflow of £1.7mln for the period, a reversal from a £6.4mln cash inflow in the prior year caused primarily by seasonal mixings and a change in the client mix.'
To be fair the share had risen 20-30% recently. I wonder if long term they will just focus on health stuff? More and more of their business is now US based. Has Huntsworth now peaked? See what happens.
Results haven't gone down too well. Is it the increase in debt? Totally transformed company after being in the doldrums for a long time. The fall looks harsh to me.
"This expansion of Huntsworth makes it an even more compelling alternative to the large holding company networks."
'This statement regarding management's views as to the accretive nature of this transaction is not a profit forecast and should not be interpreted to mean that the Group's earnings per share will necessarily match or exceed the historic earnings of the Group.
Huntsworth plc - www.huntsworth.com '
17 July 2018
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014 ("MAR").
17 July 2018
Huntsworth plc
("Huntsworth" or the "Company" or the "Group")
Acquisition of Giant Creative Strategy LLC for a cash consideration of $72.2m
Huntsworth plc, the healthcare and communications group, today announces the acquisition of approximately 90.2% of the membership interests of Giant Creative Holdings, LLC, a limited liability company and parent of Giant Creative Strategy LLC ("Giant") from Shamrock Capital Growth Fund III L.P. and its affiliates and Giant's former and existing management, for a cash consideration of $72.2m funded from existing debt facilities.
Transaction highlights
Giant, based in San Francisco, is one of the largest independent healthcare marketing agencies based on the US west coast. It provides a full service, multichannel offering to its clients in the biopharmaceutical, medical device and diagnostics companies, through its circa 150 staff and derives circa 70% of its revenue from marketing to healthcare professionals ('HCPs'), a key growth area for Huntsworth. When combined with our existing Healthcare marketing agencies led by New York-based Evoke, the Group will be significantly more competitive in responding to changing client demand that is seeking fewer but stronger partners to help access the spectrum of their marketing needs.
Giant's management team is led by founders Steven Gold (CEO) and Adam Gelling (President) who will remain with the business and who hold, along with other senior management, the remaining circa 9.8% of Giant Creative Holdings, LLC's equity which is subject to put and call rights that are exercisable in March of each calendar year commencing in 2021 (the "Put and Call"). The value of the Put and Call will be determined based on a multiple of Giant's earnings over the two-year period prior to exercise of the Put and Call, subject to a cap of $25 million in the aggregate. Consequently, the maximum aggregate consideration payable by Huntsworth for Giant will be $97.2 million. Giant generated revenues of circa $32m and EBITDA of circa $7m in the year to 31 December 2017 and the Group expects the acquisition to be materially accretive to the Group's earnings in the current financial year. Giant's gross assets were $26.1m as at 31 December 2017. Huntsworth is entitled to settle any consideration due under the Put and Call either in cash, by the issue of ordinary shares in the Company ("Shares") or by a mixture of cash and the issue of Shares.
Commenting on the acquisition, Paul Taaffe, Group CEO, said:
"We are delighted to welcome Giant into Huntsworth. Giant is a strong addition to the Group, bringing scale in Healthcare professional ('HCP') marketing especially in the fast growth biotech sector and is led by an outstanding management team who will continue to be invested alongside us in the business.
"This expansion of Huntswort
CORRECTION: " I would NOT put my shirt on these shares"
Regarding RKH ….…..I am nicely in profit as I bought at 25p...…...but I am fairly confident that in 2 or 3 years time these shares will be five times their current price of 35p. I would put my shirt on these shares......but I consider them a fair punt! I also hold CNA...….and think that they are worth getting into.....for a good dividend and share price increase...….especially after a market correction. I think HNT might be worth getting back into.....but probably at around 60 -70p
Looks like a bit of profit taking in last few days. Looks like some of the exisiting fund have decided to reduce here.
You can never call it exactly when to buy or sell.
Yes Gotrader, I pulled out too soon. and I could have bought two very nice new cars with the profit I could have made. But in the past, I have held on too long......with the same results. Now I am retired...….and with the market looking so toppy......I think I made a reasonable decision to take profits. At least I can sleep peacefully at nights. But one is plagued with 'could have' 'should have' thoughts.....I just have to drive them from my mind. I did say that I felt I might live to regret it. I should maybe have sold 2/3rds. We live and learn. But my feeling now is that opportunities to make money in this market are running thin. I think I shall wait for the next roll of the dice.
Such a quiet forum but this share keeps surging ahead. I wonder if you should of sold out fully here Ahha? RKH is retracing back to 30p. You could of had 50% more here. That's another 50k. FIL buying too here.
Share above 110p now. Those that bought at 37p have trebled their monies.
Well I guessed this yesterday based on the number of shares.The Wellcome Trust Limited, as Trustee of The Wellcome Trust has sold all it's shares here. You normally save these kind of RNS to the end of the day.
Brokers predicted �1.07 quite a while ago
Up 5% today. What is going on?
Shares are infuriating. Had I held on I would have got a nice juicy dividend and a better sell price......I sold at 96p but only got 92.5p because it was the best price I could get for selling a large number of shares. I really thought I was ripped off...�.but what can you do? They may go even higher.....but there again the market might pop at any moment. I must be satisfied with the profit I made.
Seemed to be a reasonable trading update. Healthcare division doing good. Also net debt falling too. More acquisitions on the way. Share shot up to 107p today at one point. 44m shares traded. 16,683,109 is the exact holding of The Wellcome Trust Limited as a Trustee of The Wellcome Trust . Likely they have sold out or switched holding to another trust? Likely other contender is Aberforth Partners LLP? Have to wait for the RNS here. All trades happened at 98.5p so these are all arranged. Gives a strong indication that 98.5p is at least fair value here.
My friend is really bullish on this now. He is not worried about 40p price. He thinks it could go further. Oil price is still rising and is now about 80 dollars. Should of mentioned your share tips to him much sooner. As for HNT I see no reason for this to fall any time soon.
As for HNT.....I may live to regret selling out of this share. It is looking robust at the moment and the dividend is to be announced in a few days time. Still , I made a really good profit and at least I am sleeping well at nights. A major correction could come at any time.....and I am mostly in cash now waiting on the side lines.
Its been a volatile week! I very much doubt if they will fall below 30p now. And the fundamentals are all in place the...... oil is there. I think by 2020 this share will flourish. And yes, I have no doubt that Trump has engineered an oil rise in accordance with his strategy to promote America and American businessmen. There is some speculation that oil could be �90 by 2020 and remember also that oil shares tend to rise at the close of a bull market.